This was pivotal year for MannKind in which it gained Food and Drug Administration approval for inhaled insulin Afrezza after multiple attempts. The biotech even signed up a stellar partner,Sanofi, to ...
All things considered, it's been an exceptionally strong year for healthcare conglomerate Johnson & Johnson and its shareholders. Although the stock market in general has had a strong year, Johnson & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results